Cargando…
Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer
BACKGROUND: Magnetic fluids containing superparamagnetic iron oxide nanoparticles represent an attractive platform as nanocarriers in chemotherapy. Recently, we developed a formulation of maghemite nanoparticles coated with rhodium (II) citrate, which resulted in in vitro cytotoxicity enhanced up to...
Autores principales: | Carneiro, Marcella Lemos Brettas, Peixoto, Raphael CA, Joanitti, Graziela A, Oliveira, Ricardo GS, Telles, Luis AM, Miranda-Vilela, Ana L, Bocca, Anamélia L, Vianna, Leonora MS, da Silva, Izabel CR, de Souza, Aparecido R, Lacava, Zulmira GM, Báo, Sônia N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598481/ https://www.ncbi.nlm.nih.gov/pubmed/23414068 http://dx.doi.org/10.1186/1477-3155-11-4 |
Ejemplares similares
-
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy
por: Carneiro, Marcella LB, et al.
Publicado: (2011) -
Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay
por: Peixoto, Raphael Cândido Apolinário, et al.
Publicado: (2014) -
Modulation of fibronectin and laminin expression by Rhodium (II) citrate-coated maghemite nanoparticles in mice bearing breast tumor
por: Rocha, Márcia, et al.
Publicado: (2017) -
Acute and subchronic toxicity of the antitumor agent rhodium (II) citrate in Balb/c mice after intraperitoneal administration
por: Carneiro, Marcella L.B., et al.
Publicado: (2015) -
Exploring cellular uptake of iron oxide nanoparticles associated with rhodium citrate in breast cancer cells
por: Chaves, Natalia L, et al.
Publicado: (2017)